Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 106 shares at $15.01 ($2K) on 2022-09-15, disclosed to the SEC on 2022-09-19.
Scheduled sale ($2k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TRDA | SELL | 2023-08-04 | $771K | — | Filing → |
| TRDA | SELL | 2023-03-03 | $17K | — | Filing → |
| TRDA | SELL | 2023-01-03 | $70K | — | Filing → |